Omega-3 fatty acids and dyslipidemic agent for lipid therapy

Details for Australian Patent Application No. 2005314361 (hide)

Owner Reliant Pharmaceuticals, Inc.

Inventors Bobotas, George; Rongen, Roelof M. L.

Agent Davies Collison Cave

Pub. Number AU-B-2005314361

PCT Pub. Number WO2006/062748

Priority 60/699,866 18.07.05 US; 60/633,125 06.12.04 US; 60/659,099 08.03.05 US

Filing date 22 November 2005

Wipo publication date 15 June 2006

Acceptance publication date 12 April 2012

International Classifications

A61K 31/225 (2006.01)

Event Publications

19 July 2007 PCT application entered the National Phase

  PCT publication WO2006/062748 Priority application(s): WO2006/062748

12 April 2012 Application Accepted

  Published as AU-B-2005314361

19 July 2012 Alteration of Name

  The name of the applicant has been altered to GlaxoSmithKline LLC 2006

23 August 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005314365-Friction draft gear housing having a removable end wall

2005314359-Facial and neck muscle exercising device